85 related articles for article (PubMed ID: 11102556)
1. Expression of wild-type and mutant human ornithine transcarbamylase genes in Chinese hamster ovary cells and lack of dominant negative effect of R141Q and R40H mutants.
Augustin L; Mavinakere M; Morizono H; Tuchman M
Pediatr Res; 2000 Dec; 48(6):842-6. PubMed ID: 11102556
[TBL] [Abstract][Full Text] [Related]
2. In vivo assessment of mutations in OTC for dominant-negative effects following rAAV2/8-mediated gene delivery to the mouse liver.
Ginn SL; Cunningham SC; Zheng M; Spinoulas A; Carpenter KH; Alexander IE
Gene Ther; 2009 Jun; 16(6):820-3. PubMed ID: 19357713
[TBL] [Abstract][Full Text] [Related]
3. Expression analysis of two mutant human ornithine transcarbamylases in COS-7 cells.
Kogo T; Satoh Y; Kanazawa M; Yamamoto S; Takayanagi M; Ohtake A; Mori M; Niimi H
J Hum Genet; 1998; 43(1):54-8. PubMed ID: 9609999
[TBL] [Abstract][Full Text] [Related]
4. The clinically variable R40H mutant ornithine carbamoyltransferase shows cytosolic degradation of the precursor protein in CHO cells.
Mavinakere M; Morizono H; Shi D; Allewell NM; Tuchman M
J Inherit Metab Dis; 2001 Nov; 24(6):614-22. PubMed ID: 11768581
[TBL] [Abstract][Full Text] [Related]
5. The biochemical and molecular spectrum of ornithine transcarbamylase deficiency.
Tuchman M; Morizono H; Rajagopal BS; Plante RJ; Allewell NM
J Inherit Metab Dis; 1998; 21 Suppl 1():40-58. PubMed ID: 9686344
[TBL] [Abstract][Full Text] [Related]
6. Engineering mRNA translation initiation to enhance transient gene expression in chinese hamster ovary cells.
Underhill MF; Coley C; Birch JR; Findlay A; Kallmeier R; Proud CG; James DC
Biotechnol Prog; 2003; 19(1):121-9. PubMed ID: 12573014
[TBL] [Abstract][Full Text] [Related]
7. 'Late onset' ornithine transcarbamylase deficiency: function of three purified recombinant mutant enzymes.
Morizono H; Listrom CD; Rajagopal BS; Aoyagi M; McCann MT; Allewell NM; Tuchman M
Hum Mol Genet; 1997 Jun; 6(6):963-8. PubMed ID: 9175746
[TBL] [Abstract][Full Text] [Related]
8. Patient selection may affect gene therapy success. Dominant negative effects observed for ornithine transcarbamylase in mouse and human hepatocytes.
Morsy MA; Zhao JZ; Ngo TT; Warman AW; O'Brien WE; Graham FL; Caskey CT
J Clin Invest; 1996 Feb; 97(3):826-32. PubMed ID: 8609240
[TBL] [Abstract][Full Text] [Related]
9. An arginine to glutamine mutation in residue 109 of human ornithine transcarbamylase completely abolishes enzymatic activity in Cos1 cells.
Lee JT; Nussbaum RL
J Clin Invest; 1989 Dec; 84(6):1762-6. PubMed ID: 2556444
[TBL] [Abstract][Full Text] [Related]
10. Identification and characterization of two novel mutations (Q421 K and R123P) in congenital factor XII deficiency.
Kanaji T; Kanaji S; Osaki K; Kuroiwa M; Sakaguchi M; Mihara K; Niho Y; Okamura T
Thromb Haemost; 2001 Dec; 86(6):1409-15. PubMed ID: 11776307
[TBL] [Abstract][Full Text] [Related]
11. In vitro demonstration of intra-locus compensation using the ornithine transcarbamylase protein as model.
Suriano G; Azevedo L; Novais M; Boscolo B; Seruca R; Amorim A; Ghibaudi EM
Hum Mol Genet; 2007 Sep; 16(18):2209-14. PubMed ID: 17613537
[TBL] [Abstract][Full Text] [Related]
12. [Mapping the silver fox genome. IV. Determination of chromosomal location of genes for ornithine carbamoyltransferase and prion protein].
Koroleva IV; Khlebodarova TM; Rubtsov NB; Zakiian SM
Genetika; 1994 Jun; 30(6):839-42. PubMed ID: 7958796
[TBL] [Abstract][Full Text] [Related]
13. The R40H mutation in a late onset type of human ornithine transcarbamylase deficiency in male patients.
Nishiyori A; Yoshino M; Kato H; Matsuura T; Hoshide R; Matsuda I; Kuno T; Miyazaki S; Hirose S; Kuromaru R; Mori M
Hum Genet; 1997 Feb; 99(2):171-6. PubMed ID: 9048915
[TBL] [Abstract][Full Text] [Related]
14. Mutations and polymorphisms in the human ornithine transcarbamylase gene: mutation update addendum.
Tuchman M; Plante RJ
Hum Mutat; 1995; 5(4):293-5. PubMed ID: 7627182
[TBL] [Abstract][Full Text] [Related]
15. Expression of human chromosome 2 ornithine decarboxylase gene in ornithine decarboxylase-deficient Chinese hamster ovary cells.
Hsieh JT; Denning MF; Heidel SM; Verma AK
Cancer Res; 1990 Apr; 50(8):2239-44. PubMed ID: 2317811
[TBL] [Abstract][Full Text] [Related]
16. Ornithine transcarbamylase and arginase I deficiency are responsible for diminished urea cycle function in the human hepatoblastoma cell line HepG2.
Mavri-Damelin D; Eaton S; Damelin LH; Rees M; Hodgson HJ; Selden C
Int J Biochem Cell Biol; 2007; 39(3):555-64. PubMed ID: 17098461
[TBL] [Abstract][Full Text] [Related]
17. Dominant-negative p53 mutations in rheumatoid arthritis.
Han Z; Boyle DL; Shi Y; Green DR; Firestein GS
Arthritis Rheum; 1999 Jun; 42(6):1088-92. PubMed ID: 10366100
[TBL] [Abstract][Full Text] [Related]
18. Dominant-negative control of cAMP-dependent IKs upregulation in human long-QT syndrome type 1.
Heijman J; Spätjens RL; Seyen SR; Lentink V; Kuijpers HJ; Boulet IR; de Windt LJ; David M; Volders PG
Circ Res; 2012 Jan; 110(2):211-9. PubMed ID: 22095730
[TBL] [Abstract][Full Text] [Related]
19. Transfection of a nonactive site mutant murine DHFR cDNA (the tryptophan 15 mutant) into Chinese hamster ovary and mouse marrow progenitor cells imparts MTX resistance in vitro.
Banerjee D; Zhao SC; Tong Y; Steinherz J; Gritsman K; Bertino JR
Cancer Gene Ther; 1994 Sep; 1(3):181-4. PubMed ID: 7621249
[TBL] [Abstract][Full Text] [Related]
20. Proportions of spontaneous mutations in males and females with ornithine transcarbamylase deficiency.
Tuchman M; Matsuda I; Munnich A; Malcolm S; Strautnieks S; Briede T
Am J Med Genet; 1995 Jan; 55(1):67-70. PubMed ID: 7702100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
